Treace Medical Concepts (TMCI) to Release Quarterly Earnings on Thursday

Treace Medical Concepts (NASDAQ:TMCI) is expected to be posting its quarterly earnings results after the market closes on Thursday, February 27th. Analysts expect Treace Medical Concepts to post earnings of ($0.04) per share and revenue of $67.19 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Treace Medical Concepts Price Performance

TMCI opened at $9.59 on Tuesday. The stock has a market cap of $597.46 million, a P/E ratio of -9.69 and a beta of 0.75. Treace Medical Concepts has a 52-week low of $3.92 and a 52-week high of $14.81. The company has a quick ratio of 2.98, a current ratio of 4.12 and a debt-to-equity ratio of 0.51. The business has a fifty day moving average of $8.73 and a 200 day moving average of $7.15.

Wall Street Analyst Weigh In

TMCI has been the subject of several research reports. BTIG Research raised shares of Treace Medical Concepts from a “neutral” rating to a “buy” rating and set a $16.00 price objective for the company in a research report on Tuesday, February 4th. Stifel Nicolaus upped their target price on Treace Medical Concepts from $7.00 to $8.00 and gave the stock a “hold” rating in a report on Wednesday, November 6th. Truist Financial lifted their target price on Treace Medical Concepts from $7.00 to $8.40 and gave the company a “hold” rating in a research note on Wednesday, December 18th. Lake Street Capital assumed coverage on shares of Treace Medical Concepts in a research report on Tuesday, December 31st. They issued a “buy” rating and a $14.50 price objective on the stock. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and set a $8.00 target price on shares of Treace Medical Concepts in a research report on Tuesday, December 17th. Five investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $9.99.

Treace Medical Concepts Company Profile

Treace Medical Concepts, Inc, a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity.